Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials

Stem Cell Research and Therapy

Volumn 5, Issue 2, 2014, Pages

  Zhu, Yongzhao ^a,b   Yang, Yinxue ^a   Zhang, Yaolin ^a   Hao, Guiliang ^a   Liu, Ting ^a   Wang, Libin ^a   Yang, Tingting ^a   Wang, Qiong ^a   Zhang, Guangyi ^a   Wei, Jun ^a   Li, Yukui ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b NINGXIA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; POLYINOSINIC POLYCYTIDYLIC ACID; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIGENS, CD200; LEUKOCYTE ANTIGEN;

ALLOTRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FULL THICKNESS SKIN GRAFT; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTHER FETUS RELATIONSHIP; MOUSE; MOUSE MODEL; NONHUMAN; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SKIN TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PREGNANCY; PROCEDURES;

ANIMALS; ANTIGENS, CD; CELL PROLIFERATION; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; PLACENTA; PREGNANCY;

EID: 84900477827     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt436     Document Type: Article

References (38)

1. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ, Stem Cells 2002 20 530 541 10.1634/stemcells.20-6-530 12456961 (Pubitemid 35463066)
2. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
3. Immunosuppressive properties of mesenchymal stem cells: advances and applications. De Miguel M, Fuentes-Julián S, Blázquez- Martínez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F, Curr Mol Med 2012 12 574 591 10.2174/156652412800619950 22515979
4. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, Mosca JD, J Biomed Sci 2003 10 228 241 10.1007/BF02256058 12595759 (Pubitemid 36302404)
5. CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells. Pietilä M, Lehtonen S, Tuovinen E, Lähteenmäki K, Laitinen S, Leskelä HV, Nätynki A, Pesälä J, Nordström K, Lehenkari P, PLoS One 2012 7 31671 10.1371/journal.pone.0031671 22363701
6. The involvement of oxidants and NF-κB in cytokine-induced MMP-9 synthesis by bone marrow-derived osteoprogenitor cells. Ben-David D, Livne E, Reznick AZ, Inflamm Res 2012 61 673 688 10.1007/s00011-012-0461-7 22410640
7. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Neuss S, Becher E, Wöltje M, Tietze L, Jahnen-Dechent W, Stem Cells 2004 22 405 414 10.1634/stemcells.22-3-405 15153617 (Pubitemid 38736624)
8. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Standal T, Abildgaard N, Fagerli UM, Stordal B, Hjertner O, Borset M, Sundan A, Blood 2007 109 3024 3030 17138824 (Pubitemid 46482103)
9. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo. Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I, Stem Cells 2012 30 266 279 10.1002/stem.787 22102554
10. Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Li X, Ling W, Pennisi A, Wang Y, Khan S, Heidaran M, Pal A, Zhang X, He S, Zeitlin A, Abbot S, Faleck H, Hariri R, Shaughnessy JD Jr, van Rhee F, Nair B, Barlogie B, Epstein J, Yaccoby S, Stem Cells 2011 29 263 273 10.1002/stem.572 21732484
11. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Klopp A, Gupta A, Spaeth E, Andreeff M, Marini F 3rd, Stem Cells 2011 29 11 19 10.1002/stem.559 21280155
12. Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Parolini O, Alviano F, Bergwerf I, Boraschi D, De Bari C, De Waele P, Dominici M, Evangelista M, Falk W, Hennerbichler S, Hess DC, Lanzoni G, Liu B, Marongiu F, McGuckin C, Mohr S, Nolli ML, Ofir R, Ponsaerts P, Romagnoli L, Solomon A, Soncini M, Strom S, Surbek D, Venkatachalam S, Wolbank S, Zeisberger S, Zeitlin A, Zisch A, Borlongan CV, Stem Cells Dev 2010 19 143 154 10.1089/scd.2009.0404 19947828
13. Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. Raynaud CM, Maleki M, Lis R, Ahmed B, Al-Azwani I, Malek J, Safadi FF, Rafii A, Stem Cells Int 2012 2012 658356 22701494
14. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Lee JM, Jung J, Lee HJ, Jeong SJ, Cho KJ, Hwang SG, Kim GJ, Int Immunopharmacol 2012 13 219 224 10.1016/j.intimp.2012.03.024 22487126
15. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Al Talabani AA, Knawy BA, Stem Cell Rev 2013 9 16 31 10.1007/s12015-012-9385-4 22628114
16. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K, Stem Cell Dev 2008 17 1095 1107 10.1089/scd.2007.0154
17. Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-term placenta and bone marrow. Jaramillo-Ferrada PA, Wolvetang EJ, Cooper-White JJ, J Cell Physiol 2012 227 3234 3242 10.1002/jcp.24014 22105866
18. Characterization of placenta-derived mesenchymal stem cells cultured in autologous human cord blood serum. Wang L, Yang Y, Zhu Y, Ma X, Liu T, Zhang G, Fan H, Ma L, Jin Y, Yan X, Wei J, Li Y, Mol Med Rep 2012 6 760 766 22824952
19. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH, Stem Cells 2004 22 1338 1345 10.1634/stemcells.2004-0058 15579651 (Pubitemid 39636409)
20. Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells. Roelen DL, van der Mast BJ, In't Anker PS, Kleijburg C, Eikmans M, van Beelen E, de Groot-Swings GM, Fibbe WE, Kanhai HH, Scherjon SA, Claas FH, Hum Immunol 2009 70 16 23 10.1016/j.humimm.2008.10.016 19010366
21. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. Gorczynski R, Chen Z, Kai Y, Lee L, Wong S, Marsden PA, J Immunol 2004 172 7744 7749 10.4049/jimmunol.172.12.7744 15187158 (Pubitemid 38747642)
22. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN, Sedgwick JD, Science 2000 290 1768 1771 11099416 (Pubitemid 32004808)
23. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Matsumoto K, Nakamura T, Biochem Biophys Res Commun 1997 239 639 644 10.1006/bbrc.1997.7517 9367820 (Pubitemid 27504153)
24. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25 + Foxp3+ regulatory T cells. Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH, Proc Natl Acad Sci U S A 2010 107 6424 6429 10.1073/pnas.0912437107 20332205
25. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells. Chen D, Ma F, Xu S, Chen F, Rong L, Chi Y, Zhao Q, Lu S, Han Z, Pang A, Han Z, Cytotherapy 2013 15 423 433 10.1016/j.jcyt.2012.12.001 23352460
26. Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Hass R, Otte A, Cell Commun Signal 2012 10 26 10.1186/1478-811X-10-26 22943670
27. Alternative sources of adult stem cells: human amniotic membrane. Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A, Adv Biochem Eng Biotechnol 2010 123 1 27 20237903
28. Isolation and characterization of mesenchymal cells from human fetal membranes. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O, J Tissue Eng Regen Med 2007 1 296 305 10.1002/term.40 18038420
29. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Brooke G, Tong H, Levesque JP, Atkinso K, Stem Cells Dev 2008 17 929 940 10.1089/scd.2007.0156 18564033
30. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC, Stem Cells 2004 22 1330 1337 10.1634/stemcells.2004-0013 15579650 (Pubitemid 39636408)
31. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Majore I, Moretti P, Stahl F, Hass R, Kasper C, Stem Cell Rev 2011 7 17 31 20596801
32. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K, Stem Cells 2006 24 1294 1301 10.1634/stemcells.2005- 0342 16410387 (Pubitemid 44464698)
33. Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. Hwang JH, Shim SS, Seok OS, Lee HY, Woo SK, Kim BH, Song HR, Lee JK, Park YK, J Korean Med Sci 2009 24 547 554 10.3346/jkms.2009.24.4.547 19654931
34. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. Gaebel R, Furlani D, Sorg H, Polchow B, Frank J, Bieback K, Wang W, Klopsch C, Ong LL, Li W, Ma N, Steinhoff G, PLoS One 2011 6 15652 10.1371/journal.pone.0015652 21347366
35. Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skingraft survival in association with local increases in Foxp3 (+) Treg and mast cells. Gorczynski RM, Chen Z, Khatri I, Yu K, Transpl Immunol 2011 25 187 193 10.1016/j.trim.2011.07.006 21801836
36. Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1. Rygiel TP, Luijk B, Meyaard L, Expert Opin Ther Pat 2013 23 389 392 10.1517/13543776.2013.765406 23351009
37. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H, J Immunol 2008 180 2581 2587 10.4049/jimmunol.180.4.2581 18250469
38. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Wu Y, Chen L, Scott PG, Tredget EE, Stem Cells 2007 25 2648 2659 10.1634/stemcells.2007-0226 17615264 (Pubitemid 47582758)